baito logo
    navigation?.buttons?.createJob?.text
    Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP header
    Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP logo
    #translationalemedizin #drugdiscovery #klinischeforschung

    Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP

    from Frankfurt

    The Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP is a leading research institute that develops innovative methods for the early detection and therapy of immunological diseases. With locations in Frankfurt, Hamburg, Göttingen, Berlin, and Penzberg, it promotes interdisciplinary collaboration and patient-oriented research.

    Visit website

    Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP

    The Fraunhofer ITMP is a leading research institute focused on the development of innovative methods for early detection, diagnosis, and therapy of diseases caused by impaired immune system functions. With locations in Frankfurt am Main, Hamburg, Göttingen, Berlin, and Penzberg/Munich, the institute works closely with universities and industry to translate scientific findings into practical applications.

    Research Focus Areas

    • Drug Discovery: Development of new active substances and therapies.
    • Preclinical Research: Application of modern technologies for disease research.
    • Clinical Research: Conducting studies to evaluate new therapies.

    Locations and Expertise

    • Frankfurt am Main: Focus on pharmacology and clinical studies.
    • Hamburg: World leader in high-throughput screening of chemical molecules.
    • Göttingen: Focus on neuroinflammation and nanoscopy.
    • Berlin: Research on allergies and mast cell-mediated diseases.
    • Penzberg/Munich: Immunology, infectious diseases, and pandemic research.

    Mission and Values

    The Fraunhofer ITMP sees itself as a bridge builder between science and industry, aiming to develop innovative solutions for inadequately treatable diseases. It places great importance on interdisciplinary collaboration and exchange with national and international partners.

    Sustainability Goals and Initiatives

    Although specific sustainability goals are not explicitly mentioned, the institute focuses on developing sustainable medical solutions by integrating patient perspectives and promoting personalized medicine. The involvement of patients in research projects, such as in the IMPACT initiative, demonstrates the focus on patient-oriented research.

    Current Developments

    The Fraunhofer ITMP is involved in various innovative projects, including the development of synthetic data for personalized medicine as part of the Innovative Health Initiative (IHI) and the organization of symposia to promote new therapeutic approaches. Additionally, an Early Clinical Trial Unit has been established in Göttingen to support early clinical studies.

    Sources: